Results 161 to 170 of about 34,440,044 (184)

Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

New England Journal of Medicine
openaire   +2 more sources

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia

Journal of Cerebral Blood Flow and Metabolism, 2011
Shinichiro Teramoto, Kenji Yatomi, Nobutaka Hattori   +2 more
exaly  

Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns

Trends in Endocrinology and Metabolism, 2018
Kyoung Min Kim, Soo Lim, Michael A. Nauck   +2 more
exaly  

No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials

Diabetes/Metabolism Research and Reviews, 2018
Jin Yang, Qing Tian, Tianpei Hong
exaly  

Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis

Anaesthesia
Tim Spelman, Cade Shadbolt, Peter Choong
exaly  

Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis

Diabetes, 2015
Daniel J. Drucker, Jonathan Campbell, Thomas Secher   +2 more
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis

Gastroenterology
Sena Cakir Colak, Yu-Cheng Chang
exaly  

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis

Clinical Gastroenterology and Hepatology
Antonio Facciorusso
exaly